Johnson & Johnson has announced plans to separate its orthopedics business into an independent company.
Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences industry.
In corporate restructuring news, this move is part of the company's strategy.
Johnson & Johnson’s plan to separate its orthopedics division into a standalone company
Author's summary: Johnson & Johnson separates orthopedics unit.